Invesaro

Stocks EEFT Financial statements

Financial statements

EURONET WORLDWIDE, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data EURONET WORLDWIDE, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1,9592,2522,5372,7502,4832,9963,3593,6883,9904,244
Cost of revenue1,1751,3561,4881,5561,577
Gross profit7848961,0481,194906
Selling, general and administrative165190217212222252285297315372
Operating expenses2,1792,2752,4362,8122,9733,2553,4873,714
Operating income25026635847546.6184385433503530
Interest expense28.332.637.636.236.638.337.555.680.584.5
Interest income1.72.441.321.971.040.7215.223.823.2
Other non-operating income-16.9-9.66-63-41.4-38.5-48.4-62.8-32.2-54.3-81.6
Pre-tax income2332562954348.17136323400449448
Income tax58.899.462.887.111.565.191.9121143135
Net income to minority interests-0.320.1-0.72-0.050.1-0.2-0.3-0.20.33.5
Net income174157233347-3.470.7231280306310
EBITDA330361464587174320521566635668
EPS, basic3.342.994.526.49-0.061.344.605.776.827.40
EPS, diluted3.232.854.266.31-0.061.324.415.506.456.84
Shares, basic (weighted)52.352.551.553.452.752.650.248.544.941.8
Shares, diluted (weighted)5455.154.654.952.753.553.551.648.145.8

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents7342803857861,4201,2611,1311,2541,2791,040
Receivables503745203202118203271371285335
Inventory78.195.7
Other current assets192245158218273195359316297312
Total current assets1,5851,8902,0882,9193,3663,3083,7274,1634,0374,270
Property, plant and equipment202268292360378345337332330375
Lease right-of-use assets378162161150143132154
Goodwill6907177047446666428288488591,042
Intangible assets16515111414212297.8188168189261
Other non-current assets70.7114123116233190174182227298
Total assets2,7133,1403,3214,6584,9274,7445,4045,8945,8356,489
Accounts payable45749572.981.7148194222241224269
Accrued liabilities210301211247289268312255322350
Deferred revenue44.25259.358.673.47765.456.756.460
Short-term debt32.241.3386.090.80.820.1813813983
Total current liabilities1,1791,4081,3781,6341,8551,8532,3542,7013,2263,855
Long-term debt5624045901,0911,4381,4201,6091,7151,1341,038
Lease liabilities24210711110395.887.4101
Other non-current liabilities20.564.16355.443.458.26585.985.795
Total liabilities1,8121,9412,0883,0783,4813,4894,1594,6454,6055,166
Total debt59444501,0976821,4211,6091,7151,1341,038
Paid-in capital1,0461,0721,1041,1901,2281,2741,2521,3121,3701,550
Retained earnings2794376701,0171,0131,0841,3481,6281,9342,243
Treasury stock-215-217-392-464-703-931-1,106-1,488-1,755-2,425
Other comprehensive income-211-94.5-151-165-94.2-173-251-203-322-61.7
Shareholders' equity9001,1991,2331,5791,4461,2551,2451,2501,2291,308
Minority interests1.010.960.170.070.280.04-0.2-0.20.515
Total equity9011,1991,2331,5791,4461,2561,2441,2501,2291,323
Total liabilities and equity2,7133,1403,3214,6584,9274,7445,4045,8945,8356,489
Shares outstanding52.352.851.854.2

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income174157232347-3.370.5231280306313
Depreciation and amortization80.595106112127136136133132139
Stock-based compensation1515.616.821.42236.544.153.743.955.1
Deferred income tax2.17-9.71.258.21-30.42.47.712.919.7-22
Change in receivables-87.7-19826.5-87.963.6-108-299-191270-128
Change in inventory-6.71-11.6
Change in payables257106-37.698.511993608
Cash from operations392286397504254406748643733560
Capital expenditures-87.4-97.2-112-131-97.6-92.2-104-94.4-117-126
Acquisitions-55.90-12.9-94.2-1.1-343-1.3-91.624
Cash from investing-136-102-132-229-106-98.1-454-158-223-139
Debt issued0001,195
Debt repaid-49-49-49
Stock issued4.19.517.113.115.87.85.9
Share buybacks-77.4-3.07-178-74.5-242-230-176-378-269-668
Cash from financing79.5-1612.0241635.4-212-1.2-143-136-789
Exchange rate effect-25.565.2-36.5-5.3398.8-110-389-86.1-133242
Net change in cash30988.4230686282-13.4-95.3256241-125
Free cash flow304189285373156314644549616434
Interest paid14.420.523.613.117.318.529.153.278.370.3
Income taxes paid43.248.684.474.160.248.786.294.5109153

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $65.61 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Operating margin11.5%Operating income / revenue.
EBITDA margin15.0%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin10.6%Pre-tax income / revenue.
Net margin6.6%Net income / revenue.
FCF margin6.1%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin9.2%Cash from operations / revenue.
Effective tax rate36.8%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)23.4%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)4.4%Net income / average total assets.
Return on invested capital (ROIC)17.2%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue9.0%Selling, general and administrative expense / revenue.
Stock-based pay / revenue1.4%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue3.0%Capital expenditures / revenue.
D&A / revenue3.5%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y6.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y8.1%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y11.3%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y5.3%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y11.2%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y62.6%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y5.2%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y8.6%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y30.9%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y1.1%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y10.2%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y6.0%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y15.8%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y-23.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-9.2%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y17.2%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-29.5%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-12.3%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y22.7%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y6.4%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y1.7%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-2.0%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y11.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y6.3%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y5.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-4.8%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-5.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-2.8%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.37xCurrent assets / current liabilities.
Quick ratio0.49x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.38x(Cash + short-term investments) / current liabilities.
Debt / equity1.49xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets28.1%Total debt / total assets.
Liabilities / assets80.8%Total liabilities / total assets.
Net debt$630.1MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA0.96xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage7.05xOperating income / interest expense.
Working capital$1.17BCurrent assets - current liabilities.
Goodwill and intangibles / assets19.5%(Goodwill + intangible assets) / total assets.
Tangible book value-$36.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.67xRevenue / average total assets.
Fixed asset turnover11.8xRevenue / average property, plant and equipment.
Receivables turnover12.0xRevenue / average receivables.
Days sales outstanding30 days365 x average receivables / revenue.
FCF conversion93.2%Free cash flow / net income, when net income is positive.
Capex / operating cash flow33.0%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$6.25Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$94.74Revenue / diluted weighted shares.
FCF per share$5.82Free cash flow / diluted weighted shares.
Operating cash flow per share$8.69Cash from operations / diluted weighted shares.
Book value per share$26.63Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$0.80Tangible book value / shares outstanding.
Cash per share$25.92(Cash + short-term investments) / shares outstanding.
Buybacks / FCF188.6%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$2.45BShare price x shares outstanding.
Enterprise value$3.08BMarket cap + total debt - cash - short-term investments.
P/E8.51xMarket cap / net income. Only when net income is positive.
P/S0.56xMarket cap / revenue.
P/B2.00xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF9.13xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF6.12xMarket cap / cash from operations, when positive.
EV/Sales0.71xEnterprise value / revenue.
EV/EBIT6.11xEnterprise value / operating income, when both are positive.
EV/EBITDA4.69xEnterprise value / EBITDA, when both are positive.
EV/FCF11.5xEnterprise value / free cash flow, when both are positive.
FCF yield11.0%Free cash flow / market cap.
Earnings yield11.8%Net income / market cap (the inverse of P/E).
Shareholder yield20.7%(Dividends paid + share buybacks) / market cap.
PEG0.54xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was EURONET WORLDWIDE, INC.'s revenue in fiscal 2025?

EURONET WORLDWIDE, INC. reported revenue of $4.24B for fiscal 2025, 6.4% higher than the year before.

Was EURONET WORLDWIDE, INC. profitable in fiscal 2025?

Yes. Net income was $309.5M, a net margin of 7.3%.

How much free cash flow did EURONET WORLDWIDE, INC. generate in fiscal 2025?

Cash from operations of $559.8M minus capital expenditures of $125.5M left free cash flow of $434.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to EURONET WORLDWIDE, INC.